Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography

Sleep Apnea Clinical Trial

Official title:

Validation of Breathing Event Detection of the REMstar Auto With Aflex Compared to Clinical Polysomnography

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00836758
• Other study ID #: EDILP-2008-SST-01
• Status: Completed
• Phase: N/A
• Start date: February 2009
• Est. completion date: August 2009

Study information

• Verified date: December 2018
• Source: Philips Respironics
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study is to compare the performance of a CPAP (continuous positive airway pressure) device to a clinical polysomnography (PSG) in identifying breathing events in patients with obstructive sleep apnea.

Description:

Purpose: The purpose of this study was to compare the AED algorithm used in a PAP device with manually scored events on PSG. The PAP device was modified to produce a square wave voltage output identifying when apneas, hypopneas, and snoring events were detected. Recording this event signal on the PSG performed with the patient using the PAP device allowed an event-by-event comparison between manually scored PSG events and AED events. In addition, the AHI, AI, and HI derived from the manually scored PSG were compared with the respective measures reported by the PAP device used during the PSG.

Study Objectives: Compare automatic event detection (AED) of respiratory events using a positive airway pressure (PAP) device with manual scoring of polysomnography (PSG) during PAP treatment of obstructive sleep apnea (OSA).

Design: Prospective PSGs of patients using a PAP device.

Setting: Six academic and private sleep disorders centers.

Interventions: A signal generated by the PAP device identifying the AED of respiratory events based on airflow was recorded during PSG.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 115
• Est. completion date: August 2009
• Est. primary completion date: August 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 75 Years

Eligibility

Inclusion Criteria:

1. Age 21-75

2. Diagnosis of OSAHS with a baseline AHI = 15 events/hr of sleep assessed January 01, 2007 or later

3. CPAP prescription of 8cm of H20 or higher

4. Able and willing to provide written informed consent

5. Native English speaker

Exclusion Criteria:

1. Participation in another interventional research study within the last 30 days

2. Major medical or psychiatric condition that would interfere with the demands of the study and adherence to PAP. Examples include unstable cardiovascular disease (Class III / IV CHF), neuromuscular disease, cancer, and renal failure.

3. Chronic respiratory failure or insufficiency with suspected or known neuromuscular disease, moderate or severe continuous positive airway pressure (COPD) or other pulmonary disorders, or any condition with an elevation of arterial carbon dioxide levels (> 45 mmHg) while awake, or subjects requiring continuous oxygen therapy.

4. Surgery of the upper airway, nose, sinus, or middle ear within the previous 90 days

5. Surgery at any time for the treatment of OSAHS such as uvulopalatopharyngoplasty (UPPP)

6. Presence of untreated or poorly managed,non-OSAHS related sleep disorders:

1. moderate to severe periodic limb movements(= 30/hr with symptoms or arousals)

2. arousals associated with periodic limb movements > 10 per hour or

3. anyone experiencing chronic and severe insomnia.

7. Consumption of ethanol immediately prior to the research PSG

Related Conditions & MeSH terms

• Sleep Apnea

Intervention

Device:
• Analysis with AED and manual PSG scoring
The CPAP device will be set-up at a sub-therapeutic pressure and will remain at this pressure for the entire night, if tolerated. Then the events will be analyzed with Automatic Event Detection (AED) and manual PSG scoring.

Locations

Country	Name	City	State
United States	Shands and UF Sleep Disorder Center	Gainesville	Florida

Sponsors (1)

Lead Sponsor	Collaborator
Philips Respironics

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Apnea-hypopnea Indices (AHI) as Determined by Polysomnography (PSG) vs Automatic Event Detection (AED ) Algorithm	Apnea-hypopnea index (AHI) is the combined average number of apneas and hypopneas that occur per hour of sleep. The Apnea index (AI) is the average number of apneas that occur per hour of sleep. The Hypopnea index (HI) is the average number of hypopneas that occur per hour of sleep.; The PSGs were manually scored to determine the apnea-hypopnea index. This value was then compared to the PAP device which utilized the AED algorithm to determine the apnea-hypopnea index.	one night
Secondary	Methodological Comparisons of AHI, Apnea Index (AI) and Hypopnea Index (HI) as Determined by Intra-class Correlation (ICC)	Methodological comparisons utilizing ICC for detection of AHI, apnea index (AI) and hypopnea index (HI) were caculated between the values obtained by PSG and the REMstar Auto with A-Flex device.	one night